Sun Pharma and Ranbaxy Laboratories are trading higher after Competition Commission of India (CCI) approved the acquisition of Ranbaxy by Sun Pharma.
Sun Pharma so far has jumped 3 per cent to touch a high at Rs. 829. Now, the stock is up 1.9 per cent at Rs. 845. The BSE counter has registered trades of around 46,000 shares, against its two-week daily average volume of 195,000 shares.
Ranbaxy Laboratories jumped to high of Rs. 651 and now, the stock is up 3 per cent at Rs. 644.
On the BSE counter, so far, 80,000 shares are traded, when compared with its two-week daily average volume of 122,000 shares.
Meanwhile, the BSE Sensex is up four points at 28,124.
Sun Pharma so far has jumped 3 per cent to touch a high at Rs. 829. Now, the stock is up 1.9 per cent at Rs. 845. The BSE counter has registered trades of around 46,000 shares, against its two-week daily average volume of 195,000 shares.
Ranbaxy Laboratories jumped to high of Rs. 651 and now, the stock is up 3 per cent at Rs. 644.
On the BSE counter, so far, 80,000 shares are traded, when compared with its two-week daily average volume of 122,000 shares.
Meanwhile, the BSE Sensex is up four points at 28,124.
No comments:
Post a Comment